SIMILAR PATTERNS OF AMINO ACIDS FOR 2W3B_B_FOLB401

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cz3 DIHYDROFOLATE
REDUCTASE


(Thermotoga
maritima)
PF00186
(DHFR_1)
5 ALA A   8
PHE A  31
ILE A  51
LEU A  55
THR A 121
None
0.63A 2w3bB-1cz3A:
16.1
2w3bB-1cz3A:
28.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1dr6 DIHYDROFOLATE
REDUCTASE


(Gallus gallus)
PF00186
(DHFR_1)
10 ILE A   7
ALA A   9
LEU A  22
PHE A  34
ILE A  60
PRO A  61
ASN A  64
LEU A  67
TYR A 121
THR A 136
HBI  A 198 (-4.1A)
HBI  A 198 ( 3.6A)
NAP  A 191 ( 4.7A)
HBI  A 198 (-4.1A)
None
None
None
None
None
HBI  A 198 ( 4.5A)
0.62A 2w3bB-1dr6A:
32.3
2w3bB-1dr6A:
74.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dwa MYROSINASE MA1

(Sinapis alba)
PF00232
(Glyco_hydro_1)
5 ILE M 185
PHE M 140
ILE M  50
ASN M  49
THR M 255
None
None
GOL  M 933 ( 4.8A)
None
None
1.14A 2w3bB-1dwaM:
undetectable
2w3bB-1dwaM:
17.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jmo HEPARIN COFACTOR II

(Homo sapiens)
PF00079
(Serpin)
5 ILE A 460
LEU A 375
PHE A 458
PRO A 477
LEU A 380
None
1.17A 2w3bB-1jmoA:
undetectable
2w3bB-1jmoA:
16.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ne2 HYPOTHETICAL PROTEIN
TA1320


(Thermoplasma
acidophilum)
PF06325
(PrmA)
5 ILE A 139
PHE A 128
PRO A 116
LEU A 151
THR A 135
None
1.18A 2w3bB-1ne2A:
2.9
2w3bB-1ne2A:
22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1u70 DIHYDROFOLATE
REDUCTASE


(Mus musculus)
PF00186
(DHFR_1)
10 ILE A   7
ALA A   9
PHE A  31
PHE A  34
ILE A  60
PRO A  61
ASN A  64
LEU A  67
TYR A 121
THR A 136
MTX  A 187 (-3.8A)
NDP  A 188 (-3.6A)
MTX  A 187 (-4.3A)
MTX  A 187 (-4.3A)
MTX  A 187 ( 4.2A)
MTX  A 187 (-4.8A)
MTX  A 187 (-3.6A)
MTX  A 187 ( 4.5A)
None
MTX  A 187 (-4.4A)
0.32A 2w3bB-1u70A:
30.8
2w3bB-1u70A:
89.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1u71 DIHYDROFOLATE
REDUCTASE


(Homo sapiens)
PF00186
(DHFR_1)
9 ILE A   7
ALA A   9
PHE A  34
ILE A  60
PRO A  61
ASN A  64
LEU A  67
TYR A 121
THR A 136
MXA  A 187 (-4.5A)
MXA  A 187 (-3.6A)
MXA  A 187 (-3.9A)
MXA  A 187 ( 4.7A)
MXA  A 187 (-4.4A)
MXA  A 187 (-4.5A)
None
None
MXA  A 187 (-4.3A)
0.39A 2w3bB-1u71A:
32.3
2w3bB-1u71A:
99.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ur1 ENDOXYLANASE

(Cellvibrio
mixtus)
PF00331
(Glyco_hydro_10)
5 ILE A 241
LEU A 263
PHE A 312
ILE A 322
ASN A  34
None
1.05A 2w3bB-1ur1A:
undetectable
2w3bB-1ur1A:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1z2i MALATE DEHYDROGENASE

(Agrobacterium
tumefaciens)
PF02615
(Ldh_2)
5 ALA A 102
PHE A 277
ILE A 115
LEU A 281
THR A  99
None
1.15A 2w3bB-1z2iA:
undetectable
2w3bB-1z2iA:
19.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1zdr DIHYDROFOLATE
REDUCTASE


(Geobacillus
stearothermophilus)
PF00186
(DHFR_1)
7 ILE A   5
ALA A   7
LEU A  20
PHE A  31
ILE A  50
LEU A  54
THR A 115
None
None
None
SO4  A3486 (-4.1A)
SO4  A3486 ( 4.8A)
SO4  A3486 (-4.2A)
None
0.53A 2w3bB-1zdrA:
20.2
2w3bB-1zdrA:
33.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2blb DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE


(Plasmodium
vivax)
PF00186
(DHFR_1)
9 ILE A  13
ALA A  15
LEU A  45
PHE A  57
ILE A 121
PRO A 122
LEU A 128
TYR A 179
THR A 194
CP7  A1240 (-4.1A)
CP7  A1240 (-3.7A)
NDP  A1239 (-4.8A)
CP7  A1240 ( 4.1A)
MES  A1241 ( 4.1A)
None
MES  A1241 (-4.5A)
None
CP7  A1240 (-4.1A)
0.64A 2w3bB-2blbA:
22.0
2w3bB-2blbA:
29.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2db3 ATP-DEPENDENT RNA
HELICASE VASA


(Drosophila
melanogaster)
PF00270
(DEAD)
PF00271
(Helicase_C)
5 ILE A 455
LEU A 285
PHE A 431
ILE A 276
PRO A 302
None
1.02A 2w3bB-2db3A:
undetectable
2w3bB-2db3A:
15.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ejx STK_08120

(Sulfurisphaera
tokodaii)
PF11485
(DUF3211)
5 ILE A  20
PHE A  26
ILE A  31
ASN A 115
LEU A 119
None
1.06A 2w3bB-2ejxA:
undetectable
2w3bB-2ejxA:
20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f3o PYRUVATE
FORMATE-LYASE 2


(Archaeoglobus
fulgidus)
PF01228
(Gly_radical)
PF02901
(PFL-like)
5 ILE A 303
LEU A 164
PHE A 285
PHE A 250
LEU A 351
None
1.04A 2w3bB-2f3oA:
undetectable
2w3bB-2f3oA:
13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h2q BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE


(Trypanosoma
cruzi)
PF00186
(DHFR_1)
PF00303
(Thymidylat_synt)
7 ALA A  28
PHE A  52
ILE A  84
PRO A  85
LEU A  91
TYR A 160
THR A 178
NAP  A 523 (-3.7A)
None
None
None
None
None
None
0.47A 2w3bB-2h2qA:
21.9
2w3bB-2h2qA:
18.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2lnu UNCHARACTERIZED
PROTEIN


(Haloarcula
marismortui)
PF07920
(DUF1684)
5 LEU A 130
PHE A  86
PRO A 111
ASN A 169
LEU A 171
None
1.15A 2w3bB-2lnuA:
undetectable
2w3bB-2lnuA:
22.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nwh CARBOHYDRATE KINASE

(Agrobacterium
fabrum)
PF00294
(PfkB)
5 ALA A  43
LEU A 260
PHE A 185
ILE A 181
LEU A 174
None
1.03A 2w3bB-2nwhA:
undetectable
2w3bB-2nwhA:
19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oh3 COG1633:
UNCHARACTERIZED
CONSERVED PROTEIN


(Magnetospirillum
magnetotacticum)
PF02915
(Rubrerythrin)
5 ILE A  56
ALA A  14
LEU A  68
TYR A 111
THR A  17
None
1.15A 2w3bB-2oh3A:
undetectable
2w3bB-2oh3A:
19.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oip CHAIN A, CRYSTAL
STRUCTURE OF DHFR


(Cryptosporidium
hominis)
PF00186
(DHFR_1)
PF00303
(Thymidylat_synt)
7 ALA A  11
LEU A  25
PHE A  36
ILE A  62
LEU A  67
TYR A 119
THR A 134
MTX  A 605 ( 3.6A)
MTX  A 605 ( 4.6A)
MTX  A 605 ( 4.1A)
MTX  A 605 ( 4.6A)
MTX  A 605 ( 4.4A)
None
MTX  A 605 ( 4.2A)
0.54A 2w3bB-2oipA:
22.5
2w3bB-2oipA:
17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pef SERINE PROTEASE
INHIBITOR


(Caldanaerobacter
subterraneus)
PF00079
(Serpin)
5 LEU A 313
PHE A 401
ASN A  80
LEU A  82
TYR A 267
None
1.12A 2w3bB-2pefA:
undetectable
2w3bB-2pefA:
20.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2po4 VIRION RNA
POLYMERASE


(Escherichia
virus N4)
no annotation 5 ALA A 294
LEU A  62
PHE A  81
ILE A 284
TYR A 217
None
1.15A 2w3bB-2po4A:
undetectable
2w3bB-2po4A:
12.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qik UPF0131 PROTEIN YKQA

(Bacillus
subtilis)
PF06094
(GGACT)
PF13772
(AIG2_2)
5 PHE A 143
ILE A 194
PRO A 195
LEU A 202
TYR A 259
None
0.99A 2w3bB-2qikA:
undetectable
2w3bB-2qikA:
20.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2qk8 DIHYDROFOLATE
REDUCTASE


(Bacillus
anthracis)
PF00186
(DHFR_1)
6 ALA A   8
LEU A  21
ILE A  51
LEU A  55
TYR A 102
THR A 115
MTX  A 200 ( 3.4A)
MTX  A 200 ( 4.5A)
MTX  A 200 ( 4.2A)
MTX  A 200 ( 4.1A)
None
MTX  A 200 ( 4.4A)
0.87A 2w3bB-2qk8A:
20.8
2w3bB-2qk8A:
34.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2veo LIPASE A

(Moesziomyces
antarcticus)
PF03583
(LIP)
5 ILE A 150
ALA A 148
ILE A 301
PRO A 300
LEU A 305
PG4  A1443 ( 4.1A)
None
None
None
None
1.08A 2w3bB-2veoA:
undetectable
2w3bB-2veoA:
17.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2w3w DIHYDROFOLATE
REDUCTASE


(Mycobacterium
avium)
PF00186
(DHFR_1)
6 ALA A  11
PHE A  35
PRO A  55
LEU A  61
TYR A 108
THR A 121
VG9  A1168 ( 3.8A)
VG9  A1168 (-3.9A)
VG9  A1168 ( 4.6A)
VG9  A1168 ( 4.4A)
None
VG9  A1168 ( 4.7A)
0.39A 2w3bB-2w3wA:
21.9
2w3bB-2w3wA:
31.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2w9s DIHYDROFOLATE
REDUCTASE TYPE 1
FROM TN4003


(Staphylococcus
aureus)
PF00186
(DHFR_1)
7 ILE A   5
ALA A   7
LEU A  20
ILE A  50
LEU A  54
TYR A  98
THR A 111
TOP  A1160 (-4.2A)
TOP  A1160 ( 3.6A)
TOP  A1160 ( 4.2A)
TOP  A1160 (-4.4A)
None
None
TOP  A1160 ( 4.5A)
0.67A 2w3bB-2w9sA:
20.6
2w3bB-2w9sA:
32.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2zii VACUOLAR PROTEIN
SORTING-ASSOCIATED
PROTEIN 74


(Saccharomyces
cerevisiae)
PF05719
(GPP34)
5 ILE A 287
ALA A 254
PHE A 291
ILE A 318
LEU A 298
None
1.17A 2w3bB-2ziiA:
undetectable
2w3bB-2ziiA:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3b78 EXOTOXIN A

(Pseudomonas
aeruginosa)
PF09009
(Exotox-A_cataly)
5 ILE B 594
ALA B 425
ILE B 571
PRO B 572
TYR B 502
None
1.17A 2w3bB-3b78B:
undetectable
2w3bB-3b78B:
21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3bwt PROTEIN PUF4

(Saccharomyces
cerevisiae)
PF00806
(PUF)
5 ILE A 716
LEU A 694
PHE A 706
LEU A 745
THR A 677
None
0.93A 2w3bB-3bwtA:
undetectable
2w3bB-3bwtA:
21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d7n FLAVODOXIN,
WRBA-LIKE PROTEIN


(Agrobacterium
fabrum)
PF03358
(FMN_red)
5 ILE A  38
LEU A 114
PHE A  76
ILE A  58
LEU A  52
None
1.06A 2w3bB-3d7nA:
undetectable
2w3bB-3d7nA:
22.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dfr DIHYDROFOLATE
REDUCTASE


(Lactobacillus
casei)
PF00186
(DHFR_1)
6 ALA A   6
LEU A  19
PHE A  30
PRO A  50
LEU A  54
THR A 116
MTX  A 164 (-3.8A)
MTX  A 164 (-4.5A)
MTX  A 164 ( 4.0A)
MTX  A 164 ( 4.6A)
MTX  A 164 ( 4.4A)
MTX  A 164 ( 4.3A)
0.71A 2w3bB-3dfrA:
20.8
2w3bB-3dfrA:
31.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dg8 BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE


(Plasmodium
falciparum)
PF00186
(DHFR_1)
9 ILE A  14
ALA A  16
LEU A  46
PHE A  58
ILE A 112
PRO A 113
LEU A 119
TYR A 170
THR A 185
RJ6  A 609 (-4.5A)
RJ6  A 609 (-3.7A)
RJ6  A 609 (-3.8A)
RJ6  A 609 (-4.3A)
RJ6  A 609 (-4.8A)
None
RJ6  A 609 (-4.4A)
NDP  A 610 ( 4.9A)
RJ6  A 609 ( 4.5A)
0.51A 2w3bB-3dg8A:
22.5
2w3bB-3dg8A:
25.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dkp PROBABLE
ATP-DEPENDENT RNA
HELICASE DDX52


(Homo sapiens)
PF00270
(DEAD)
5 ILE A 376
LEU A 205
PHE A 352
ILE A 196
PRO A 222
None
1.06A 2w3bB-3dkpA:
undetectable
2w3bB-3dkpA:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3dwo PROBABLE OUTER
MEMBRANE PROTEIN


(Pseudomonas
aeruginosa)
PF03349
(Toluene_X)
5 ILE X 373
ALA X   1
PHE X   3
ASN X 238
LEU X 282
C8E  X 454 ( 4.0A)
None
C8E  X 454 ( 4.7A)
None
C8E  X 454 ( 4.9A)
1.09A 2w3bB-3dwoX:
undetectable
2w3bB-3dwoX:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3emy TRICHODERMA REESEI
ASPARTIC PROTEASE


(Trichoderma
reesei)
PF00026
(Asp)
5 ILE A 268
LEU A 203
PHE A 257
ILE A 207
LEU A 223
None
1.13A 2w3bB-3emyA:
undetectable
2w3bB-3emyA:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fa3 2,3-DIMETHYLMALATE
LYASE


(Aspergillus
niger)
PF13714
(PEP_mutase)
5 ILE A 238
PRO A 240
ASN A 214
LEU A 212
THR A 101
None
OAF  A 501 (-4.0A)
OAF  A 501 (-3.6A)
None
None
0.97A 2w3bB-3fa3A:
undetectable
2w3bB-3fa3A:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3gbz KINASE, CMGC CDK

(Giardia
intestinalis)
PF00069
(Pkinase)
5 ALA A 165
LEU A  66
ILE A 157
LEU A 137
TYR A  26
None
1.11A 2w3bB-3gbzA:
undetectable
2w3bB-3gbzA:
22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3i8a DIHYDROFOLATE
REDUCTASE


(Staphylococcus
aureus)
PF00186
(DHFR_1)
6 ALA X   7
LEU X  20
ILE X  50
LEU X  54
TYR X  98
THR X 111
N22  X 219 ( 3.6A)
N22  X 219 ( 4.6A)
N22  X 219 (-4.6A)
None
None
N22  X 219 (-4.4A)
0.83A 2w3bB-3i8aX:
20.3
2w3bB-3i8aX:
29.03
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ia4 DIHYDROFOLATE
REDUCTASE


(Moritella
profunda)
PF00186
(DHFR_1)
7 ILE A   6
ALA A   8
PHE A  32
ILE A  51
LEU A  55
TYR A 102
THR A 115
MTX  A 164 (-4.0A)
MTX  A 164 ( 3.7A)
MTX  A 164 (-4.1A)
MTX  A 164 (-4.1A)
MTX  A 164 ( 4.4A)
None
MTX  A 164 (-4.3A)
0.60A 2w3bB-3ia4A:
20.7
2w3bB-3ia4A:
31.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ix9 DIHYDROFOLATE
REDUCTASE


(Streptococcus
pneumoniae)
PF00186
(DHFR_1)
6 ILE A   8
ALA A  10
LEU A  23
PHE A  34
LEU A  58
THR A 119
MTX  A 200 (-4.1A)
MTX  A 200 (-3.8A)
NDP  A 193 ( 4.1A)
MTX  A 200 (-4.4A)
MTX  A 200 ( 4.0A)
MTX  A 200 ( 4.5A)
0.70A 2w3bB-3ix9A:
20.7
2w3bB-3ix9A:
31.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kao TAGATOSE
1,6-DIPHOSPHATE
ALDOLASE


(Staphylococcus
aureus)
PF01791
(DeoC)
5 ALA A  57
PHE A  26
ILE A  49
LEU A  32
THR A  61
None
0.98A 2w3bB-3kaoA:
undetectable
2w3bB-3kaoA:
23.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kjr DIHYDROFOLATE
REDUCTASE/THYMIDYLAT
E SYNTHASE


(Babesia bovis)
PF00186
(DHFR_1)
PF00303
(Thymidylat_synt)
6 ALA A  16
ILE A  73
PRO A  74
LEU A  80
TYR A 129
THR A 144
NAP  A 512 (-3.7A)
None
None
None
None
None
0.79A 2w3bB-3kjrA:
23.0
2w3bB-3kjrA:
23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nas BETA-PHOSPHOGLUCOMUT
ASE


(Bacillus
subtilis)
PF13419
(HAD_2)
5 ILE A 129
ALA A 119
LEU A   8
ILE A  96
LEU A 100
None
1.17A 2w3bB-3nasA:
2.9
2w3bB-3nasA:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nyf D-ARGININE
DEHYDROGENASE


(Pseudomonas
aeruginosa)
PF01266
(DAO)
5 ALA A1047
LEU A1258
PRO A1261
ASN A1263
THR A1147
None
0.95A 2w3bB-3nyfA:
undetectable
2w3bB-3nyfA:
17.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o5c CYTOCHROME C551
PEROXIDASE


(Shewanella
oneidensis)
PF00034
(Cytochrom_C)
PF03150
(CCP_MauG)
5 ALA A 165
ILE A 118
PRO A 117
LEU A  52
TYR A 149
None
None
HEM  A 401 (-4.2A)
None
None
1.14A 2w3bB-3o5cA:
undetectable
2w3bB-3o5cA:
20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3onk EPSIN-3

(Saccharomyces
cerevisiae)
PF01417
(ENTH)
5 ILE A  87
ALA A  90
PHE A  73
ASN A 114
THR A  40
None
1.03A 2w3bB-3onkA:
undetectable
2w3bB-3onkA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oss TYPE 2 SECRETION
SYSTEM, SECRETIN
GSPD


(Escherichia
coli)
PF03958
(Secretin_N)
5 ILE D  41
ALA D   7
ILE D  18
LEU D  60
THR D  43
None
1.11A 2w3bB-3ossD:
undetectable
2w3bB-3ossD:
23.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qvm OLEI00960

(Oleispira
antarctica)
PF00561
(Abhydrolase_1)
5 ILE A 101
ALA A 114
ILE A 243
PRO A 244
ASN A 245
None
1.16A 2w3bB-3qvmA:
undetectable
2w3bB-3qvmA:
21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3r4c HYDROLASE, HALOACID
DEHALOGENASE-LIKE
HYDROLASE


(Bacteroides
thetaiotaomicron)
PF08282
(Hydrolase_3)
5 ALA A 100
PHE A 149
ILE A  82
ASN A 179
LEU A 166
None
1.07A 2w3bB-3r4cA:
undetectable
2w3bB-3r4cA:
20.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rg9 BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE


(Trypanosoma
brucei)
PF00186
(DHFR_1)
6 ALA A  34
PHE A  58
PRO A  91
LEU A  97
TYR A 166
THR A 184
WRA  A 602 (-3.9A)
WRA  A 602 (-3.9A)
WRA  A 602 (-4.3A)
None
None
WRA  A 602 (-4.2A)
0.54A 2w3bB-3rg9A:
21.9
2w3bB-3rg9A:
29.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rh9 SUCCINATE-SEMIALDEHY
DE DEHYDROGENASE
(NAD(P)(+))


(Marinobacter
hydrocarbonoclasticus)
PF00171
(Aldedh)
5 ALA A 168
PHE A 114
PHE A 115
ILE A 159
LEU A  82
None
1.13A 2w3bB-3rh9A:
undetectable
2w3bB-3rh9A:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3sft CHEMOTAXIS RESPONSE
REGULATOR
PROTEIN-GLUTAMATE
METHYLESTERASE


(Thermotoga
maritima)
PF01339
(CheB_methylest)
5 ILE A 279
LEU A 283
ILE A 177
ASN A 179
LEU A 180
None
1.01A 2w3bB-3sftA:
undetectable
2w3bB-3sftA:
21.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tq9 DIHYDROFOLATE
REDUCTASE


(Coxiella
burnetii)
PF00186
(DHFR_1)
7 ILE A   6
ALA A   8
LEU A  21
PHE A  32
ILE A  51
LEU A  55
THR A 115
MTX  A2001 (-4.0A)
MTX  A2001 ( 3.4A)
MTX  A2001 (-4.4A)
MTX  A2001 (-4.3A)
MTX  A2001 (-4.3A)
MTX  A2001 ( 4.5A)
MTX  A2001 (-4.3A)
0.56A 2w3bB-3tq9A:
21.1
2w3bB-3tq9A:
30.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3um6 BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE


(Plasmodium
falciparum)
PF00186
(DHFR_1)
PF00303
(Thymidylat_synt)
8 ILE A  14
LEU A  46
PHE A  58
ILE A 112
PRO A 113
LEU A 119
TYR A 170
THR A 185
1CY  A 609 (-4.3A)
NDP  A 610 (-4.4A)
1CY  A 609 (-3.5A)
1CY  A 609 (-4.4A)
None
None
None
1CY  A 609 (-4.3A)
0.64A 2w3bB-3um6A:
22.4
2w3bB-3um6A:
14.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ut3 PLASMINOGEN
ACTIVATOR INHIBITOR
1


(Homo sapiens)
PF00079
(Serpin)
5 LEU A 275
PHE A 358
PHE A 360
ASN A  31
TYR A 228
None
1.05A 2w3bB-3ut3A:
undetectable
2w3bB-3ut3A:
18.31
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vco DIHYDROFOLATE
REDUCTASE


(Schistosoma
mansoni)
PF00186
(DHFR_1)
7 ALA A   8
PHE A  32
ILE A  57
PRO A  58
LEU A  64
TYR A 117
THR A 133
None
0.72A 2w3bB-3vcoA:
23.7
2w3bB-3vcoA:
37.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3zef PRE-MRNA-SPLICING
FACTOR 8


(Saccharomyces
cerevisiae)
PF08084
(PROCT)
PF10596
(U6-snRNA_bdg)
PF10597
(U5_2-snRNA_bdg)
PF10598
(RRM_4)
PF12134
(PRP8_domainIV)
5 ILE B1400
ALA B1402
PHE B1312
ILE B1319
TYR B1389
None
1.15A 2w3bB-3zefB:
undetectable
2w3bB-3zefB:
8.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4b3i FATTY ACID
BETA-OXIDATION
COMPLEX BETA-CHAIN
FADA


(Mycobacterium
tuberculosis)
PF00108
(Thiolase_N)
PF02803
(Thiolase_C)
5 ILE C 399
ALA C 397
LEU C  96
ILE C   7
THR C 307
None
1.15A 2w3bB-4b3iC:
undetectable
2w3bB-4b3iC:
17.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4bhc METHYLATED-DNA--PROT
EIN-CYSTEINE
METHYLTRANSFERASE


(Mycobacterium
tuberculosis)
PF01035
(DNA_binding_1)
PF02870
(Methyltransf_1N)
5 ILE A 123
ALA A  50
ILE A  11
PRO A  10
LEU A 149
None
1.16A 2w3bB-4bhcA:
undetectable
2w3bB-4bhcA:
20.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4e5t MANDELATE RACEMASE /
MUCONATE LACTONIZING
ENZYME, C-TERMINAL
DOMAIN PROTEIN


(Labrenzia
alexandrii)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
5 ILE A 312
ALA A 298
LEU A 295
ILE A 327
LEU A 125
None
1.17A 2w3bB-4e5tA:
undetectable
2w3bB-4e5tA:
17.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4g8z DIHYDROFOLATE
REDUCTASE


(Pneumocystis
jirovecii)
PF00186
(DHFR_1)
10 ILE X  10
ALA X  12
LEU X  25
PHE X  36
ILE X  65
PRO X  66
ASN X  69
LEU X  72
TYR X 129
THR X 144
TOP  X 301 (-4.2A)
NDP  X 302 ( 3.8A)
TOP  X 301 ( 4.0A)
TOP  X 301 (-3.9A)
TOP  X 301 ( 4.3A)
TOP  X 301 (-4.8A)
None
None
None
TOP  X 301 (-4.5A)
0.53A 2w3bB-4g8zX:
25.3
2w3bB-4g8zX:
37.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gl0 LMO0810 PROTEIN

(Listeria
monocytogenes)
PF13416
(SBP_bac_8)
5 ILE A  46
LEU A  37
PHE A  54
ILE A 282
ASN A 283
None
1.05A 2w3bB-4gl0A:
undetectable
2w3bB-4gl0A:
20.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h96 DIHYDROFOLATE
REDUCTASE


(Candida
albicans)
PF00186
(DHFR_1)
8 ILE A   9
ALA A  11
PHE A  36
ILE A  62
PRO A  63
LEU A  69
TYR A 118
THR A 133
14Q  A 202 (-4.3A)
14Q  A 202 ( 3.7A)
14Q  A 202 (-4.0A)
14Q  A 202 ( 4.8A)
None
None
None
14Q  A 202 ( 4.6A)
0.76A 2w3bB-4h96A:
21.3
2w3bB-4h96A:
34.52
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4h98 DIHYDROFOLATE
REDUCTASE


([Candida]
glabrata)
PF00186
(DHFR_1)
9 ILE A   9
ALA A  11
LEU A  25
PHE A  36
ILE A  62
PRO A  63
LEU A  69
TYR A 127
THR A 140
14Q  A 302 (-4.1A)
14Q  A 302 ( 3.4A)
14Q  A 302 ( 4.1A)
14Q  A 302 (-3.8A)
14Q  A 302 (-4.2A)
14Q  A 302 (-4.4A)
None
None
14Q  A 302 (-4.2A)
0.50A 2w3bB-4h98A:
22.0
2w3bB-4h98A:
38.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4hz8 BETA-GLUCOSIDASE

(uncultured
bacterium)
PF00232
(Glyco_hydro_1)
5 LEU A 327
PHE A 261
ILE A 385
LEU A 367
THR A 377
None
1.05A 2w3bB-4hz8A:
undetectable
2w3bB-4hz8A:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4i3g BETA-GLUCOSIDASE

(Streptomyces
venezuelae)
PF00933
(Glyco_hydro_3)
PF01915
(Glyco_hydro_3_C)
PF14310
(Fn3-like)
5 ILE A 448
PRO A 449
ASN A 452
LEU A 476
THR A 590
None
None
None
None
SO4  A 904 (-4.5A)
0.73A 2w3bB-4i3gA:
undetectable
2w3bB-4i3gA:
13.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4k90 EXTRACELLULAR
METALLOPROTEINASE
MEP
EXTRACELLULAR
METALLOPROTEINASE
MEP


(Aspergillus
fumigatus;
Aspergillus
fumigatus)
PF02128
(Peptidase_M36)
PF07504
(FTP)
5 ALA B  48
ILE A 603
ASN A 599
LEU A 566
TYR B  45
None
1.13A 2w3bB-4k90B:
undetectable
2w3bB-4k90B:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lmo TELOMERASE REVERSE
TRANSCRIPTASE


(Takifugu
rubripes)
PF12009
(Telomerase_RBD)
5 ILE A 334
LEU A 315
PHE A 366
ILE A 424
LEU A 428
None
1.10A 2w3bB-4lmoA:
undetectable
2w3bB-4lmoA:
23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lvr INTRAFLAGELLAR
TRANSPORT PROTEIN 81


(Chlamydomonas
reinhardtii)
no annotation 5 ILE A  44
LEU A  36
PHE A  41
ILE A  99
LEU A  69
None
1.12A 2w3bB-4lvrA:
undetectable
2w3bB-4lvrA:
22.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4m2x DIHYDROFOLATE
REDUCTASE


(Mycobacterium
tuberculosis)
PF00186
(DHFR_1)
7 ILE A   5
ALA A   7
PHE A  31
PRO A  51
LEU A  57
TYR A 100
THR A 113
TMQ  A 202 (-4.0A)
TMQ  A 202 ( 3.5A)
TMQ  A 202 (-4.0A)
TMQ  A 202 (-4.2A)
None
None
TMQ  A 202 (-4.2A)
0.49A 2w3bB-4m2xA:
20.9
2w3bB-4m2xA:
32.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4m7v DIHYDROFOLATE
REDUCTASE


(Enterococcus
faecalis)
PF00186
(DHFR_1)
6 ILE A   5
ALA A   7
LEU A  20
PHE A  31
LEU A  55
THR A 116
RAR  A 200 (-4.0A)
RAR  A 200 ( 3.6A)
RAR  A 200 ( 3.7A)
RAR  A 200 (-3.8A)
RAR  A 200 (-4.2A)
RAR  A 200 (-4.4A)
0.67A 2w3bB-4m7vA:
20.0
2w3bB-4m7vA:
32.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nq3 CYANURIC ACID
AMIDOHYDROLASE


(Azorhizobium
caulinodans)
PF09663
(Amido_AtzD_TrzD)
5 ILE A  24
ALA A  28
ILE A  37
LEU A  59
THR A  26
None
1.14A 2w3bB-4nq3A:
undetectable
2w3bB-4nq3A:
19.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4p68 DIHYDROFOLATE
REDUCTASE


(Escherichia
coli)
PF00186
(DHFR_1)
6 ILE A   5
ALA A   7
PHE A  31
ILE A  50
TYR A 100
THR A 113
MTX  A 201 (-4.1A)
MTX  A 201 ( 4.0A)
MTX  A 201 (-4.1A)
MTX  A 201 (-4.7A)
None
MTX  A 201 ( 4.5A)
0.37A 2w3bB-4p68A:
20.6
2w3bB-4p68A:
32.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rt7 RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ILE A 867
LEU A 668
PHE A 801
ILE A 827
ASN A 673
None
None
None
P30  A1001 ( 4.8A)
None
0.97A 2w3bB-4rt7A:
undetectable
2w3bB-4rt7A:
19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xri PUTATIVE
UNCHARACTERIZED
PROTEIN


(Chaetomium
thermophilum)
PF03810
(IBN_N)
PF13513
(HEAT_EZ)
5 ALA A 738
LEU A 696
PHE A 713
ILE A 667
TYR A 754
None
1.01A 2w3bB-4xriA:
undetectable
2w3bB-4xriA:
12.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xtb CALCIUM UNIPORTER
PROTEIN,
MITOCHONDRIAL


(Homo sapiens)
no annotation 5 LEU A 112
PHE A 149
ILE A 141
LEU A 145
THR A 157
None
1.10A 2w3bB-4xtbA:
undetectable
2w3bB-4xtbA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3


(Homo sapiens)
PF07714
(Pkinase_Tyr)
5 ILE A 867
LEU A 668
PHE A 801
ILE A 827
ASN A 673
None
None
None
P30  A1001 (-4.7A)
None
1.14A 2w3bB-4xufA:
undetectable
2w3bB-4xufA:
21.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ypl LON PROTEASE

(Meiothermus
taiwanensis)
PF00004
(AAA)
PF05362
(Lon_C)
5 ALA A 724
LEU A 600
PRO A 736
ASN A 739
LEU A 743
None
1.04A 2w3bB-4yplA:
undetectable
2w3bB-4yplA:
15.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4z7g SERINE/THREONINE-PRO
TEIN
KINASE/ENDORIBONUCLE
ASE IRE1


(Homo sapiens)
PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A)
5 ILE A 813
ALA A 760
LEU A 669
PHE A 831
LEU A 795
None
1.17A 2w3bB-4z7gA:
undetectable
2w3bB-4z7gA:
19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ah5 LEUCINE--TRNA LIGASE

(Agrobacterium
tumefaciens)
PF00133
(tRNA-synt_1)
PF08264
(Anticodon_1)
PF13603
(tRNA-synt_1_2)
5 ILE A 438
ALA A 441
LEU A 445
ILE A 427
PRO A 426
None
1.16A 2w3bB-5ah5A:
undetectable
2w3bB-5ah5A:
12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5bz6 LYSOZYME,CALCIUM
UNIPORTER PROTEIN,
MITOCHONDRIAL


(Homo sapiens;
Escherichia
virus T4)
PF00959
(Phage_lysozyme)
5 LEU A1112
PHE A1149
ILE A1141
LEU A1145
THR A1157
None
None
None
None
SO4  A2004 (-3.3A)
1.16A 2w3bB-5bz6A:
undetectable
2w3bB-5bz6A:
17.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dxv RETHREADED DHFR

(synthetic
construct)
PF00186
(DHFR_1)
7 ILE A   5
ALA A   7
PHE A  48
ILE A  67
LEU A  71
TYR A 117
THR A 130
None
NAP  A 201 (-3.7A)
PEG  A 202 ( 3.7A)
PEG  A 202 ( 4.9A)
None
None
CME  A 140 ( 4.5A)
0.63A 2w3bB-5dxvA:
12.5
2w3bB-5dxvA:
28.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fda DIHYDROFOLATE
REDUCTASE


(Yersinia pestis)
PF00186
(DHFR_1)
6 ILE A   6
ALA A   8
ILE A  51
LEU A  55
TYR A 101
THR A 114
None
0.49A 2w3bB-5fdaA:
14.2
2w3bB-5fdaA:
32.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fii PHENYLALANINE-4-HYDR
OXYLASE


(Homo sapiens)
PF01842
(ACT)
5 ILE A  94
LEU A  41
PHE A  55
ILE A  65
LEU A  62
None
None
None
PHE  A 901 ( 4.3A)
PHE  A 901 (-3.6A)
1.10A 2w3bB-5fiiA:
undetectable
2w3bB-5fiiA:
21.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5fwx GLUTAMATE RECEPTOR 4

(Rattus
norvegicus)
PF01094
(ANF_receptor)
6 ILE B 204
ALA B 236
LEU B 358
ILE B 226
ASN B 220
LEU B 197
None
1.44A 2w3bB-5fwxB:
2.3
2w3bB-5fwxB:
17.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gpl PUTATIVE NUCLEOSOME
ASSEMBLY PROTEIN
C36B7.08C


(Schizosaccharomyces
pombe)
PF00956
(NAP)
5 ALA A 200
PHE A  49
ILE A  79
ASN A  78
LEU A  76
None
1.16A 2w3bB-5gplA:
undetectable
2w3bB-5gplA:
22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gs6 NS1 OF ZIKA VIRUS
FROM 2015 BRAZIL
STRAIN


(Zika virus)
PF00948
(Flavi_NS1)
5 LEU A 321
PHE A 323
ILE A 243
PRO A 244
LEU A 217
None
1.09A 2w3bB-5gs6A:
undetectable
2w3bB-5gs6A:
21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gvi UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 30


(Danio rerio)
PF00443
(UCH)
5 ILE A 270
LEU A 313
PHE A 244
ILE A 319
LEU A 249
None
1.07A 2w3bB-5gviA:
undetectable
2w3bB-5gviA:
18.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hus TREHALOSE SYNTHASE
REGULATORY PROTEIN


(Candida
albicans)
PF02358
(Trehalose_PPase)
5 ILE A 200
ALA A 147
ILE A 111
LEU A 207
THR A 148
None
1.06A 2w3bB-5husA:
3.0
2w3bB-5husA:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hz1 PROBABLE LRR
RECEPTOR-LIKE
SERINE/THREONINE-PRO
TEIN KINASE
AT4G26540


(Arabidopsis
thaliana)
PF13855
(LRR_8)
5 ALA B 196
LEU B 226
ILE B 234
PRO B 231
LEU B 237
None
1.10A 2w3bB-5hz1B:
undetectable
2w3bB-5hz1B:
15.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5hzl LMO2445 PROTEIN

(Listeria
monocytogenes)
no annotation 5 LEU B  37
PHE B  24
ILE B  57
PRO B  58
LEU B  72
None
1.11A 2w3bB-5hzlB:
undetectable
2w3bB-5hzlB:
21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jta NEUTRAL TREHALASE

(Saccharomyces
cerevisiae)
no annotation 5 ALA A 579
PHE A 360
ILE A 635
PRO A 632
LEU A 316
None
1.16A 2w3bB-5jtaA:
undetectable
2w3bB-5jtaA:
14.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5m4a NEUTRAL TREHALASE

(Saccharomyces
cerevisiae)
no annotation 5 ALA A 579
PHE A 360
ILE A 635
PRO A 632
LEU A 316
None
1.17A 2w3bB-5m4aA:
undetectable
2w3bB-5m4aA:
17.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ohk UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE
30,UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE
30,UBIQUITIN
CARBOXYL-TERMINAL
HYDROLASE 30


(Homo sapiens)
PF00443
(UCH)
5 ILE A 274
LEU A 317
PHE A 248
ILE A 323
LEU A 253
None
1.03A 2w3bB-5ohkA:
undetectable
2w3bB-5ohkA:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5t0l BIFUNCTIONAL
DIHYDROFOLATE
REDUCTASE-THYMIDYLAT
E SYNTHASE


(Toxoplasma
gondii)
PF00186
(DHFR_1)
PF00303
(Thymidylat_synt)
8 ALA A  10
LEU A  23
PHE A  32
PHE A  35
PRO A  88
LEU A  94
TYR A 157
THR A 172
73X  A 704 (-4.0A)
None
73X  A 704 (-4.7A)
73X  A 704 (-3.2A)
73X  A 704 (-4.0A)
None
None
73X  A 704 (-4.2A)
0.47A 2w3bB-5t0lA:
24.1
2w3bB-5t0lA:
16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5vsd HISTONE-LYSINE
N-METHYLTRANSFERASE
EHMT1


(Homo sapiens)
PF00856
(SET)
PF05033
(Pre-SET)
5 ILE A1146
ALA A1234
ILE A1021
PRO A1022
LEU A1124
None
1.17A 2w3bB-5vsdA:
undetectable
2w3bB-5vsdA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x1t PPKA-294

(Serratia sp.
FS14)
no annotation 5 ILE A 288
LEU A 233
ILE A 171
ASN A 170
LEU A 181
None
1.17A 2w3bB-5x1tA:
undetectable
2w3bB-5x1tA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b4m MONOTREME LACTATION
PROTEIN


(Ornithorhynchus
anatinus)
no annotation 5 LEU A 159
PHE A 142
PHE A 141
ILE A  51
LEU A  41
None
None
None
None
IOD  A 403 ( 4.8A)
1.12A 2w3bB-6b4mA:
undetectable
2w3bB-6b4mA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6cxm DIHYDROFOLATE
REDUCTASE


(Mycolicibacterium
smegmatis)
no annotation 7 ILE A   6
ALA A   8
PHE A  32
PRO A  52
LEU A  58
TYR A  98
THR A 111
MMV  A 202 (-4.0A)
NAP  A 201 (-3.9A)
MMV  A 202 (-3.7A)
MMV  A 202 ( 4.6A)
MMV  A 202 (-4.2A)
None
MMV  A 202 (-4.4A)
0.48A 2w3bB-6cxmA:
20.3
2w3bB-6cxmA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6e4e -

(-)
no annotation 5 ALA A   7
LEU A  20
ILE A  50
LEU A  54
THR A 111
MMV  A 202 ( 3.5A)
MMV  A 202 (-4.3A)
MMV  A 202 ( 4.9A)
None
MMV  A 202 (-4.3A)
0.71A 2w3bB-6e4eA:
20.4
2w3bB-6e4eA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1e1c METHYLMALONYL-COA
MUTASE ALPHA CHAIN


(Propionibacterium
freudenreichii)
PF01642
(MM_CoA_mutase)
PF02310
(B12-binding)
3 GLU A 690
GLN A 339
ARG A 471
None
0.90A 2w3bB-1e1cA:
undetectable
2w3bB-1e1cA:
11.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ee1 NH(3)-DEPENDENT
NAD(+) SYNTHETASE


(Bacillus
subtilis)
PF02540
(NAD_synthase)
3 GLU A  67
GLN A  59
ARG A  56
None
0.78A 2w3bB-1ee1A:
1.5
2w3bB-1ee1A:
18.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fwx NITROUS OXIDE
REDUCTASE


(Paracoccus
denitrificans)
PF13473
(Cupredoxin_1)
3 GLU A 538
GLN A  59
ARG A  51
None
0.96A 2w3bB-1fwxA:
undetectable
2w3bB-1fwxA:
15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1g1a DTDP-D-GLUCOSE
4,6-DEHYDRATASE


(Salmonella
enterica)
PF16363
(GDP_Man_Dehyd)
3 GLU A 145
GLN A 229
ARG A 231
None
0.88A 2w3bB-1g1aA:
0.3
2w3bB-1g1aA:
18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gl2 VESICLE TRANSPORT
V-SNARE PROTEIN
VTI1-LIKE 1


(Mus musculus)
PF12352
(V-SNARE_C)
3 GLU C 165
GLN C 173
ARG C 176
None
0.96A 2w3bB-1gl2C:
undetectable
2w3bB-1gl2C:
16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gl2 VESICLE TRANSPORT
V-SNARE PROTEIN
VTI1-LIKE 1
SYNTAXIN 8


(Mus musculus;
Rattus
norvegicus)
PF12352
(V-SNARE_C)
no annotation
3 GLU D 175
GLN C 173
ARG C 176
None
0.80A 2w3bB-1gl2D:
undetectable
2w3bB-1gl2D:
18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1k2p TYROSINE-PROTEIN
KINASE BTK


(Homo sapiens)
PF07714
(Pkinase_Tyr)
3 GLU A 441
GLN A 467
ARG A 468
None
0.81A 2w3bB-1k2pA:
undetectable
2w3bB-1k2pA:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1p5q FK506-BINDING
PROTEIN 4


(Homo sapiens)
PF00254
(FKBP_C)
PF00515
(TPR_1)
PF07719
(TPR_2)
3 GLU A 309
GLN A 315
ARG A 318
None
0.89A 2w3bB-1p5qA:
undetectable
2w3bB-1p5qA:
22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ryo SEROTRANSFERRIN

(Homo sapiens)
PF00405
(Transferrin)
3 GLU A  13
GLN A  20
ARG A  23
None
0.77A 2w3bB-1ryoA:
undetectable
2w3bB-1ryoA:
21.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1u70 DIHYDROFOLATE
REDUCTASE


(Mus musculus)
PF00186
(DHFR_1)
3 GLU A  30
GLN A  35
ARG A  70
MTX  A 187 (-3.0A)
MTX  A 187 (-3.7A)
MTX  A 187 (-3.1A)
0.27A 2w3bB-1u70A:
30.8
2w3bB-1u70A:
89.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1xtj PROBABLE
ATP-DEPENDENT RNA
HELICASE P47


(Homo sapiens)
PF00270
(DEAD)
PF00271
(Helicase_C)
3 GLU A 134
GLN A 323
ARG A 326
None
ADP  A 550 (-3.9A)
None
0.96A 2w3bB-1xtjA:
1.5
2w3bB-1xtjA:
20.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c5a GDP-MANNOSE-3',
5'-EPIMERASE


(Arabidopsis
thaliana)
PF01370
(Epimerase)
3 GLU A 279
GLN A 241
ARG A 304
None
GDC  A1376 (-3.8A)
None
0.98A 2w3bB-2c5aA:
undetectable
2w3bB-2c5aA:
19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dhr FTSH

(Thermus
thermophilus)
PF00004
(AAA)
PF01434
(Peptidase_M41)
3 GLU A 499
GLN A 468
ARG A 453
None
0.95A 2w3bB-2dhrA:
undetectable
2w3bB-2dhrA:
18.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2exh BETA-D-XYLOSIDASE

(Geobacillus
stearothermophilus)
PF04616
(Glyco_hydro_43)
3 GLU A 427
GLN A 404
ARG A 516
None
0.99A 2w3bB-2exhA:
undetectable
2w3bB-2exhA:
17.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gxa REPLICATION PROTEIN
E1


(Deltapapillomavirus
4)
PF00519
(PPV_E1_C)
3 GLU A 529
GLN A 527
ARG A 543
None
0.76A 2w3bB-2gxaA:
undetectable
2w3bB-2gxaA:
20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ipx RRNA
2'-O-METHYLTRANSFERA
SE FIBRILLARIN


(Homo sapiens)
PF01269
(Fibrillarin)
3 GLU A 283
GLN A 240
ARG A 219
None
MTA  A4001 (-4.0A)
MTA  A4001 (-3.9A)
0.61A 2w3bB-2ipxA:
undetectable
2w3bB-2ipxA:
20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2k60 PROTEIN (STROMAL
INTERACTION MOLECULE
1)


(Homo sapiens)
PF07647
(SAM_2)
3 GLU A 146
GLN A 188
ARG A 184
None
0.99A 2w3bB-2k60A:
undetectable
2w3bB-2k60A:
23.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2msr PC4 AND
SFRS1-INTERACTING
PROTEIN


(Homo sapiens)
PF11467
(LEDGF)
3 GLU B 379
GLN B 353
ARG B 344
None
0.94A 2w3bB-2msrB:
undetectable
2w3bB-2msrB:
22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2oud DUAL SPECIFICITY
PROTEIN PHOSPHATASE
10


(Homo sapiens)
PF00782
(DSPc)
3 GLU A 318
GLN A 409
ARG A 414
None
None
CL  A   1 ( 4.1A)
0.87A 2w3bB-2oudA:
undetectable
2w3bB-2oudA:
21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozo TYROSINE-PROTEIN
KINASE ZAP-70


(Homo sapiens)
PF00017
(SH2)
PF07714
(Pkinase_Tyr)
3 GLU A 454
GLN A 591
ARG A 594
None
0.67A 2w3bB-2ozoA:
undetectable
2w3bB-2ozoA:
15.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2q9q DNA REPLICATION
COMPLEX GINS PROTEIN
PSF1


(Homo sapiens)
no annotation 3 GLU C  12
GLN C  31
ARG C  30
None
0.76A 2w3bB-2q9qC:
undetectable
2w3bB-2q9qC:
21.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vyc BIODEGRADATIVE
ARGININE
DECARBOXYLASE


(Escherichia
coli)
PF01276
(OKR_DC_1)
PF03709
(OKR_DC_1_N)
PF03711
(OKR_DC_1_C)
3 GLU A   9
GLN A  70
ARG A  73
None
0.91A 2w3bB-2vycA:
2.9
2w3bB-2vycA:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2wjv REGULATOR OF
NONSENSE TRANSCRIPTS
1


(Homo sapiens)
PF04851
(ResIII)
PF09416
(UPF1_Zn_bind)
PF13086
(AAA_11)
PF13087
(AAA_12)
3 GLU A 394
GLN A 358
ARG A 549
None
None
SO4  A 989 (-4.2A)
1.00A 2w3bB-2wjvA:
undetectable
2w3bB-2wjvA:
14.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xse THYMINE DIOXYGENASE
JBP1


(Leishmania
tarentolae)
no annotation 3 GLU A 481
GLN A 550
ARG A 551
None
0.88A 2w3bB-2xseA:
undetectable
2w3bB-2xseA:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ylk CELLULOSE
1,4-BETA-CELLOBIOSID
ASE


(Ruminiclostridium
thermocellum)
PF00942
(CBM_3)
3 GLU A  46
GLN A  16
ARG A 101
None
0.93A 2w3bB-2ylkA:
undetectable
2w3bB-2ylkA:
21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3aeu LIGHT-INDEPENDENT
PROTOCHLOROPHYLLIDE
REDUCTASE SUBUNIT N


(Rhodobacter
capsulatus)
PF00148
(Oxidored_nitro)
3 GLU A 210
GLN A  39
ARG A  68
None
0.99A 2w3bB-3aeuA:
1.1
2w3bB-3aeuA:
16.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3byv RHOPTRY KINASE

(Toxoplasma
gondii)
PF14531
(Kinase-like)
3 GLU A 560
GLN A 525
ARG A 528
None
0.97A 2w3bB-3byvA:
undetectable
2w3bB-3byvA:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eez PUTATIVE MANDELATE
RACEMASE/MUCONATE
LACTONIZING ENZYME


(Ruegeria
pomeroyi)
PF02746
(MR_MLE_N)
PF13378
(MR_MLE_C)
3 GLU A  16
GLN A 323
ARG A 337
None
1.00A 2w3bB-3eezA:
undetectable
2w3bB-3eezA:
18.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3epv NICKEL AND COBALT
RESISTANCE PROTEIN
CNRR


(Cupriavidus
metallidurans)
PF13801
(Metal_resist)
3 GLU A  33
GLN A  38
ARG A  41
CU  A   1 (-2.3A)
None
None
0.85A 2w3bB-3epvA:
undetectable
2w3bB-3epvA:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3eya PYRUVATE
DEHYDROGENASE
[CYTOCHROME]


(Escherichia
coli)
PF00205
(TPP_enzyme_M)
PF02775
(TPP_enzyme_C)
PF02776
(TPP_enzyme_N)
3 GLU A  66
GLN A  62
ARG A 398
None
0.88A 2w3bB-3eyaA:
undetectable
2w3bB-3eyaA:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3fdg DIPEPTIDASE AC.
METALLO PEPTIDASE.
MEROPS FAMILY M19


(Rhodobacter
sphaeroides)
PF01244
(Peptidase_M19)
3 GLU A 343
GLN A 324
ARG A 328
None
0.90A 2w3bB-3fdgA:
undetectable
2w3bB-3fdgA:
18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3flu DIHYDRODIPICOLINATE
SYNTHASE


(Neisseria
meningitidis)
PF00701
(DHDPS)
3 GLU A 263
GLN A 278
ARG A 282
None
0.93A 2w3bB-3fluA:
undetectable
2w3bB-3fluA:
21.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3go9 INSULINASE FAMILY
PROTEASE


(Yersinia pestis)
PF00675
(Peptidase_M16)
PF05193
(Peptidase_M16_C)
3 GLU A  58
GLN A 401
ARG A 404
None
0.91A 2w3bB-3go9A:
undetectable
2w3bB-3go9A:
17.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3j99 SYNAPTOSOMAL-ASSOCIA
TED PROTEIN 25


(Rattus
norvegicus)
PF00835
(SNAP-25)
3 GLU M 170
GLN M  56
ARG M  59
None
0.65A 2w3bB-3j99M:
undetectable
2w3bB-3j99M:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l0a PUTATIVE EXONUCLEASE

([Eubacterium]
rectale)
PF12684
(DUF3799)
3 GLU A 221
GLN A 182
ARG A 181
None
0.93A 2w3bB-3l0aA:
undetectable
2w3bB-3l0aA:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l4k DNA TOPOISOMERASE 2

(Saccharomyces
cerevisiae)
PF00521
(DNA_topoisoIV)
PF01751
(Toprim)
PF16898
(TOPRIM_C)
3 GLU A 814
GLN A 807
ARG A 588
None
0.77A 2w3bB-3l4kA:
undetectable
2w3bB-3l4kA:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l4k DNA TOPOISOMERASE 2

(Saccharomyces
cerevisiae)
PF00521
(DNA_topoisoIV)
PF01751
(Toprim)
PF16898
(TOPRIM_C)
3 GLU A 816
GLN A 807
ARG A 588
None
0.94A 2w3bB-3l4kA:
undetectable
2w3bB-3l4kA:
13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3l8k DIHYDROLIPOYL
DEHYDROGENASE


(Sulfolobus
solfataricus)
PF02852
(Pyr_redox_dim)
PF07992
(Pyr_redox_2)
3 GLU A  36
GLN A  91
ARG A  94
None
0.67A 2w3bB-3l8kA:
undetectable
2w3bB-3l8kA:
19.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lzx FERREDOXIN--NADP
REDUCTASE 2


(Bacillus
subtilis)
PF07992
(Pyr_redox_2)
3 GLU A  75
GLN A  67
ARG A  65
None
0.87A 2w3bB-3lzxA:
1.7
2w3bB-3lzxA:
20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ml0 PENICILLIN G
ACYLASE, BETA
SUBUNIT


(Alcaligenes
faecalis)
PF01804
(Penicil_amidase)
3 GLU B 328
GLN B 375
ARG B 449
None
0.96A 2w3bB-3ml0B:
undetectable
2w3bB-3ml0B:
14.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nrk LIC12922

(Leptospira
interrogans)
PF13145
(Rotamase_2)
PF13624
(SurA_N_3)
3 GLU A 322
GLN A 161
ARG A 127
None
0.86A 2w3bB-3nrkA:
undetectable
2w3bB-3nrkA:
20.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nyo G PROTEIN-COUPLED
RECEPTOR KINASE 6


(Homo sapiens)
PF00069
(Pkinase)
PF00615
(RGS)
3 GLU A 406
GLN A 422
ARG A 435
None
0.99A 2w3bB-3nyoA:
undetectable
2w3bB-3nyoA:
15.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3otd TRNA(HIS)
GUANYLYLTRANSFERASE


(Homo sapiens)
PF04446
(Thg1)
PF14413
(Thg1C)
3 GLU A  38
GLN A 119
ARG A  49
None
0.97A 2w3bB-3otdA:
undetectable
2w3bB-3otdA:
22.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q41 GLUTAMATE [NMDA]
RECEPTOR SUBUNIT
ZETA-1


(Rattus
norvegicus)
PF01094
(ANF_receptor)
3 GLU A 277
GLN A  40
ARG A  43
None
0.94A 2w3bB-3q41A:
2.2
2w3bB-3q41A:
19.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qfw RIBULOSE-1,5-BISPHOS
PHATE
CARBOXYLASE/OXYGENAS
E LARGE SUBUNIT


(Rhodopseudomonas
palustris)
PF00016
(RuBisCO_large)
3 GLU A 245
GLN A 215
ARG A 214
None
0.98A 2w3bB-3qfwA:
undetectable
2w3bB-3qfwA:
19.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3riq TAILSPIKE PROTEIN

(Salmonella
virus 9NA)
PF09251
(PhageP22-tail)
3 GLU A 341
GLN A 404
ARG A 448
None
0.88A 2w3bB-3riqA:
undetectable
2w3bB-3riqA:
15.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rko NADH-QUINONE
OXIDOREDUCTASE
SUBUNIT M


(Escherichia
coli)
no annotation 3 GLU M 108
GLN M 361
ARG M 365
None
0.66A 2w3bB-3rkoM:
undetectable
2w3bB-3rkoM:
15.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3rrc DUFFY RECEPTOR

(Plasmodium
vivax)
PF03011
(PFEMP)
PF05424
(Duffy_binding)
3 GLU A 464
GLN A 388
ARG A 391
None
0.70A 2w3bB-3rrcA:
undetectable
2w3bB-3rrcA:
19.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3


(Homo sapiens)
PF00069
(Pkinase)
3 GLU A 140
GLN A 279
ARG A 282
None
0.80A 2w3bB-3sheA:
undetectable
2w3bB-3sheA:
19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3slk POLYKETIDE SYNTHASE
EXTENDER MODULE 2


(Saccharopolyspora
spinosa)
PF08240
(ADH_N)
PF08659
(KR)
PF13602
(ADH_zinc_N_2)
3 GLU A 484
GLN A 671
ARG A 678
None
0.99A 2w3bB-3slkA:
2.1
2w3bB-3slkA:
10.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tqe MALONYL-COA-[ACYL-CA
RRIER-PROTEIN]
TRANSACYLASE


(Coxiella
burnetii)
PF00698
(Acyl_transf_1)
3 GLU A 266
GLN A   3
ARG A 310
None
0.94A 2w3bB-3tqeA:
undetectable
2w3bB-3tqeA:
20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w3s TYPE-2 SERINE--TRNA
LIGASE


(Methanopyrus
kandleri)
PF00587
(tRNA-synt_2b)
3 GLU A 440
GLN A 493
ARG A 191
None
0.85A 2w3bB-3w3sA:
undetectable
2w3bB-3w3sA:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ani PROTEIN GRPE

(Geobacillus
kaustophilus)
PF01025
(GrpE)
3 GLU A 191
GLN A 194
ARG A 124
None
0.97A 2w3bB-4aniA:
undetectable
2w3bB-4aniA:
21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4c1n CO
DEHYDROGENASE/ACETYL
-COA SYNTHASE,
IRON-SULFUR PROTEIN


(Carboxydothermus
hydrogenoformans)
PF03599
(CdhD)
3 GLU B 275
GLN B 248
ARG B  94
None
0.69A 2w3bB-4c1nB:
undetectable
2w3bB-4c1nB:
23.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ciu CHAPERONE PROTEIN
CLPB


(Escherichia
coli)
PF00004
(AAA)
PF07724
(AAA_2)
PF10431
(ClpB_D2-small)
3 GLU A 480
GLN A 488
ARG A 491
None
0.91A 2w3bB-4ciuA:
undetectable
2w3bB-4ciuA:
14.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4di4 TATP(T) (TP0957)

(Treponema
pallidum)
PF03480
(DctP)
3 GLU B  34
GLN B 257
ARG B 256
None
0.96A 2w3bB-4di4B:
undetectable
2w3bB-4di4B:
20.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4gct NUCLEOID OCCLUSION
FACTOR SLMA


(Vibrio cholerae)
PF00440
(TetR_N)
3 GLU A 128
GLN A 136
ARG A 139
None
0.91A 2w3bB-4gctA:
undetectable
2w3bB-4gctA:
22.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4h8a UREIDOGLYCOLATE
DEHYDROGENASE


(Escherichia
coli)
PF02615
(Ldh_2)
3 GLU A 277
GLN A 285
ARG A 288
None
0.84A 2w3bB-4h8aA:
undetectable
2w3bB-4h8aA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lws UNCHARACTERIZED
PROTEIN


(Thermomonospora
curvata)
PF06013
(WXG100)
3 GLU A  88
GLN A  93
ARG A  97
None
0.94A 2w3bB-4lwsA:
undetectable
2w3bB-4lwsA:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mtn TRANSCRIPTION
TERMINATION FACTOR
NUSA


(Planctopirus
limnophila)
PF00575
(S1)
PF08529
(NusA_N)
PF13184
(KH_5)
PF14520
(HHH_5)
3 GLU A 381
GLN A 389
ARG A 392
None
0.86A 2w3bB-4mtnA:
undetectable
2w3bB-4mtnA:
21.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nr2 SERINE/THREONINE-PRO
TEIN KINASE 4


(Homo sapiens)
PF11629
(Mst1_SARAH)
3 GLU A 460
GLN A 467
ARG A 470
None
None
EDO  A 503 (-3.7A)
0.98A 2w3bB-4nr2A:
undetectable
2w3bB-4nr2A:
15.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ovr TRAP DICARBOXYLATE
TRANSPORTER, DCTP
SUBUNIT


(Xanthobacter
autotrophicus)
PF03480
(DctP)
3 GLU A 274
GLN A  34
ARG A  88
None
GTR  A 403 (-4.1A)
GTR  A 403 (-2.6A)
0.90A 2w3bB-4ovrA:
undetectable
2w3bB-4ovrA:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4qkw MUSCLE-RELATED
COILED-COIL PROTEIN


(Danio rerio)
PF15237
(PTRF_SDPR)
3 GLU A  93
GLN A 101
ARG A 104
None
0.62A 2w3bB-4qkwA:
undetectable
2w3bB-4qkwA:
21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rcn LONG-CHAIN ACYL-COA
CARBOXYLASE


(Mycobacterium
avium)
PF00289
(Biotin_carb_N)
PF01039
(Carboxyl_trans)
PF02785
(Biotin_carb_C)
PF02786
(CPSase_L_D2)
3 GLU A 241
GLN A 237
ARG A 234
None
0.97A 2w3bB-4rcnA:
undetectable
2w3bB-4rcnA:
10.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rku PHOTOSYSTEM I P700
CHLOROPHYLL A
APOPROTEIN A2
PHOTOSYSTEM I
REACTION CENTER
SUBUNIT II,
CHLOROPLASTIC


(Pisum sativum;
Pisum sativum)
PF00223
(PsaA_PsaB)
PF02531
(PsaD)
3 GLU D 136
GLN B 672
ARG B 668
None
0.92A 2w3bB-4rkuD:
undetectable
2w3bB-4rkuD:
23.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tzi TYROSINE-PROTEIN
KINASE LYN


(Mus musculus)
PF00017
(SH2)
3 GLU A 159
GLN A 142
ARG A 141
None
0.81A 2w3bB-4tziA:
undetectable
2w3bB-4tziA:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4u4p STRUCTURAL
MAINTENANCE OF
CHROMOSOMES PROTEIN
2


(Homo sapiens)
PF06470
(SMC_hinge)
3 GLU A 476
GLN A 484
ARG A 487
None
0.84A 2w3bB-4u4pA:
undetectable
2w3bB-4u4pA:
23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ubs PENTALENIC ACID
SYNTHASE


(Streptomyces
avermitilis)
PF00067
(p450)
3 GLU A  83
GLN A 187
ARG A 190
PEG  A 516 (-4.1A)
PEG  A 513 ( 4.6A)
DIF  A 502 ( 4.7A)
0.97A 2w3bB-4ubsA:
undetectable
2w3bB-4ubsA:
18.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wvr DOWN SYNDROME CELL
ADHESION MOLECULE,
ISOFORM AK


(Drosophila
melanogaster)
PF13927
(Ig_3)
3 GLU A  24
GLN A  76
ARG A  79
None
0.99A 2w3bB-4wvrA:
undetectable
2w3bB-4wvrA:
19.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a5t EUKARYOTIC
TRANSLATION
INITIATION FACTOR 3
SUBUNIT E


(Oryctolagus
cuniculus)
PF01399
(PCI)
PF09440
(eIF3_N)
3 GLU E  96
GLN E 103
ARG E 102
None
1.00A 2w3bB-5a5tE:
undetectable
2w3bB-5a5tE:
16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5anc RIBOSOME MATURATION
PROTEIN SBDS


(Homo sapiens)
PF01172
(SBDS)
PF09377
(SBDS_C)
3 GLU J  99
GLN J 106
ARG J 109
None
0.94A 2w3bB-5ancJ:
undetectable
2w3bB-5ancJ:
23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5c65 SOLUTE CARRIER
FAMILY 2,
FACILITATED GLUCOSE
TRANSPORTER MEMBER 3


(Homo sapiens)
PF00083
(Sugar_tr)
3 GLU A 252
GLN A 395
ARG A 398
None
0.97A 2w3bB-5c65A:
undetectable
2w3bB-5c65A:
16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5cw9 DE NOVO DESIGNED
FERREDOXIN-FERREDOXI
N DOMAIN INSERTION
PROTEIN


(synthetic
construct)
no annotation 3 GLU A 101
GLN A  59
ARG A  58
None
0.89A 2w3bB-5cw9A:
undetectable
2w3bB-5cw9A:
21.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5d19 TETR FAMILY
TRANSCRIPTIONAL
REGULATOR


(Mycobacterium
tuberculosis)
PF00440
(TetR_N)
PF13977
(TetR_C_6)
3 GLU A 200
GLN A  89
ARG A  93
None
0.99A 2w3bB-5d19A:
undetectable
2w3bB-5d19A:
20.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dds CRMG

(Actinoalloteichus
sp. WH1-2216-6)
PF00202
(Aminotran_3)
3 GLU A 393
GLN A 401
ARG A 404
None
0.75A 2w3bB-5ddsA:
2.1
2w3bB-5ddsA:
16.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5dfa BETA-GALACTOSIDASE

(Geobacillus
stearothermophilus)
PF02449
(Glyco_hydro_42)
PF08532
(Glyco_hydro_42M)
PF08533
(Glyco_hydro_42C)
3 GLU A 482
GLN A 520
ARG A 523
None
0.71A 2w3bB-5dfaA:
undetectable
2w3bB-5dfaA:
15.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e1r 7S VICILIN

(Carya
illinoinensis)
PF00190
(Cupin_1)
3 GLU A 405
GLN A 501
ARG A 503
None
0.76A 2w3bB-5e1rA:
undetectable
2w3bB-5e1rA:
15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5g06 EXOSOME COMPLEX
COMPONENT SKI6
EXOSOME COMPLEX
COMPONENT RRP42


(Saccharomyces
cerevisiae;
Saccharomyces
cerevisiae)
PF01138
(RNase_PH)
PF03725
(RNase_PH_C)
PF01138
(RNase_PH)
PF03725
(RNase_PH_C)
3 GLU B 125
GLN E  85
ARG E  86
None
0.92A 2w3bB-5g06B:
undetectable
2w3bB-5g06B:
22.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gz4 SNAKE VENOM
PHOSPHODIESTERASE
(PDE)


(Naja atra)
PF01033
(Somatomedin_B)
PF01223
(Endonuclease_NS)
PF01663
(Phosphodiest)
3 GLU A 580
GLN A 602
ARG A 646
None
0.94A 2w3bB-5gz4A:
2.5
2w3bB-5gz4A:
11.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5im3 RIBONUCLEOSIDE-DIPHO
SPHATE REDUCTASE


(Pseudomonas
aeruginosa)
PF00317
(Ribonuc_red_lgN)
PF02867
(Ribonuc_red_lgC)
PF03477
(ATP-cone)
3 GLU A 861
GLN A 867
ARG A 572
None
0.80A 2w3bB-5im3A:
undetectable
2w3bB-5im3A:
11.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ixm LPS-ASSEMBLY
LIPOPROTEIN LPTE


(Yersinia pestis)
PF04390
(LptE)
3 GLU B 129
GLN B 134
ARG B 137
None
0.93A 2w3bB-5ixmB:
undetectable
2w3bB-5ixmB:
20.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j9r CHOLOYLGLYCINE
HYDROLASE


(Agrobacterium
tumefaciens)
PF02275
(CBAH)
3 GLU A  71
GLN A 103
ARG A  38
None
0.99A 2w3bB-5j9rA:
undetectable
2w3bB-5j9rA:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5juf TRANSCRIPTIONAL
REGULATOR


(Streptococcus
thermophilus)
PF01381
(HTH_3)
3 GLU A  23
GLN A  36
ARG A  39
None
0.79A 2w3bB-5jufA:
undetectable
2w3bB-5jufA:
21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lm2 TYROSINE-PROTEIN
PHOSPHATASE
NON-RECEPTOR TYPE 23


(Homo sapiens)
PF13949
(ALIX_LYPXL_bnd)
3 GLU A 306
GLN A 313
ARG A 316
None
0.90A 2w3bB-5lm2A:
undetectable
2w3bB-5lm2A:
19.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5me3 SISTER CHROMATID
COHESION PROTEIN 2


(Eremothecium
gossypii)
PF12765
(Cohesin_HEAT)
PF12830
(Nipped-B_C)
3 GLU A 813
GLN A 781
ARG A 822
None
0.94A 2w3bB-5me3A:
undetectable
2w3bB-5me3A:
10.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mgv PHENYLALANINE--TRNA
LIGASE,
MITOCHONDRIAL


(Homo sapiens)
PF01409
(tRNA-synt_2d)
PF03147
(FDX-ACB)
3 GLU A 204
GLN A 192
ARG A 187
None
0.78A 2w3bB-5mgvA:
undetectable
2w3bB-5mgvA:
16.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mkk MULTIDRUG RESISTANCE
ABC TRANSPORTER
ATP-BINDING AND
PERMEASE PROTEIN
MULTIDRUG RESISTANCE
ABC TRANSPORTER
ATP-BINDING AND
PERMEASE PROTEIN


(Thermus
thermophilus;
Thermus
thermophilus)
PF00005
(ABC_tran)
PF00664
(ABC_membrane)
PF00005
(ABC_tran)
PF00664
(ABC_membrane)
3 GLU A 236
GLN A 227
ARG B 411
None
0.91A 2w3bB-5mkkA:
undetectable
2w3bB-5mkkA:
13.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mpd 26S PROTEASOME
REGULATORY SUBUNIT
RPN10


(Saccharomyces
cerevisiae)
PF13519
(VWA_2)
3 GLU W 166
GLN W 108
ARG W 101
None
0.85A 2w3bB-5mpdW:
undetectable
2w3bB-5mpdW:
23.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5mzh DYNEIN ASSEMBLY
FACTOR WITH WDR
REPEAT DOMAINS 1


(Chlamydomonas
reinhardtii)
PF00400
(WD40)
3 GLU A  44
GLN A  49
ARG A  52
SO4  A 501 (-4.5A)
None
None
0.95A 2w3bB-5mzhA:
undetectable
2w3bB-5mzhA:
15.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n2u NUCLEOPROTEIN

(Influenza D
virus)
no annotation 3 GLU A 287
GLN A  25
ARG A  29
None
0.88A 2w3bB-5n2uA:
undetectable
2w3bB-5n2uA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nhb XYLOSE ISOMERASE

(Piromyces sp.
E2)
no annotation 3 GLU A 193
GLN A 170
ARG A 166
None
0.95A 2w3bB-5nhbA:
undetectable
2w3bB-5nhbA:
18.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ojs TRANSCRIPTION-ASSOCI
ATED PROTEIN 1


(Saccharomyces
cerevisiae)
PF00454
(PI3_PI4_kinase)
PF02259
(FAT)
3 GLU T2383
GLN T2418
ARG T2415
None
0.99A 2w3bB-5ojsT:
undetectable
2w3bB-5ojsT:
4.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5twx BROMODOMAIN-CONTAINI
NG PROTEIN 9


(Homo sapiens)
PF00439
(Bromodomain)
3 GLU A 146
GLN A 151
ARG A 154
None
0.82A 2w3bB-5twxA:
undetectable
2w3bB-5twxA:
19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u8s DNA REPLICATION
LICENSING FACTOR
MCM4


(Saccharomyces
cerevisiae)
PF00493
(MCM)
PF14551
(MCM_N)
PF17207
(MCM_OB)
3 GLU 4 799
GLN 4 652
ARG 4 557
None
0.99A 2w3bB-5u8s4:
undetectable
2w3bB-5u8s4:
11.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5voc ENVELOPE
GLYCOPROTEIN H


(Human
betaherpesvirus
5)
PF02489
(Herpes_glycop_H)
PF17488
(Herpes_glycoH_C)
3 GLU A 466
GLN A 151
ARG A 365
None
0.98A 2w3bB-5vocA:
undetectable
2w3bB-5vocA:
13.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wo6 TRANSIENT RECEPTOR
POTENTIAL CATION
CHANNEL SUBFAMILY V
MEMBER 6


(Rattus
norvegicus)
PF00520
(Ion_trans)
PF12796
(Ank_2)
PF13637
(Ank_4)
3 GLU A 249
GLN A 305
ARG A 304
GLU  A 249 ( 0.6A)
GLN  A 305 ( 0.6A)
ARG  A 304 ( 0.6A)
0.79A 2w3bB-5wo6A:
undetectable
2w3bB-5wo6A:
13.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xnr ALYQ

(Persicobacter
sp. CCB-QB2)
no annotation 3 GLU A 549
GLN A 543
ARG A 452
None
None
PO4  A 604 (-3.3A)
0.81A 2w3bB-5xnrA:
undetectable
2w3bB-5xnrA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6bzh PROBABLE
ATP-DEPENDENT RNA
HELICASE DDX58


(Mus musculus)
no annotation 3 GLU A  37
GLN A  65
ARG A   6
None
0.97A 2w3bB-6bzhA:
undetectable
2w3bB-6bzhA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f5d ATP SYNTHASE GAMMA
SUBUNIT
ATP SYNTHASE DELTA
SUBUNIT


(Trypanosoma
brucei;
Trypanosoma
brucei)
no annotation
no annotation
3 GLU G 233
GLN H  40
ARG H  39
None
0.91A 2w3bB-6f5dG:
undetectable
2w3bB-6f5dG:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6g74 QUINOLINATE SYNTHASE
A


(Thermotoga
maritima)
no annotation 3 GLU A 218
GLN A  38
ARG A  41
None
0.94A 2w3bB-6g74A:
undetectable
2w3bB-6g74A:
undetectable